The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study

BACKGROUND: We hypothesized that pretreatment serum levels of insulin and other serum markers would predict Progression-free survival (PFS), defined as time to castration-resistant progression or death, in metastatic androgen-dependent prostate cancer (mADPC). METHODS: Serum samples from treatment-n...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Dayyani, Farshid, Zurita, Amado J., Nogueras-González, Graciela M., Slack, Rebecca, Millikan, Randall E., Araujo, John C., Gallick, Gary E., Logothetis, Christopher J., Corn, Paul G.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5013640/
https://ncbi.nlm.nih.gov/pubmed/27599544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2723-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados